CAH Related Analyst Ratings
-
UBS Starts Numerous Healthcare Stocks: CAH, MCK, ESRX at Buy, PMC, OCR at Neutral
-
Jefferies & Co Downgrades Cardinal Health (CAH) to Hold
-
Raymond James Upgrades Cardinal Health (CAH) to Market Perform
-
Goldman Sachs Raises Price Targets for Healthcare Services; Upgrades ABC, Downgrades PSSI
-
Deutsche Bank Downgrades Cardinal Health (CAH) to Hold; Consider AmerisourceBergen (ABC) Instead
-
Goldman Sachs Upgrades Cardinal Health (CAH) to Buy
-
Oppenheimer Downgrades Cardinal Health (CAH) to Perform
-
Lazard Capital Initiates Coverage on Cardinal Health (CAH) with a Hold
-
Cardinal Health (CAH) Sinking Again as Analysts Respond to Yesterday's Guidance
-
Baird Downgrades Cardinal Health (CAH) to Neutral
-
Jefferies & Co Initiates Coverage on Cardinal Health (CAH)
-
Auriga Reiterates a 'Buy' on Allscripts-Misys (MDRX), Raises Price Target
-
Goldman Sachs Downgrades Cardinal Health (CAH) to Neutral
-
Soleil Securities Downgrades Hospira (HSP) to Hold
-
Raymond James Downgrades Cardinal Health (CAH) to Market Perform
-
Needham Boosts Price Target on Natus Medical (BABY) to $28, Calls a Takeover Candidate
-
Goldman Sachs removed Cardinal Health (CAH) from its Conviction Buy List
-
Citigroup downgrades McKesson (MCK), Cardinal Health (CAH) and Amerisourcebergen (ABC) to Hold
-
Goldman Sachs added Cardinal Health (CAH) to their Conviction Buy list
-
Raymond James Upgrades Cardinal Health (CAH) to Strong Buy
-
Citigroup upgrades Cardinal Health (CAH) to Buy
-
Matrix USA Rating Changes 12/03
-
Matrix USA Rating Changes 11/15
-
Credit Suisse upgrades Cardinal Health (CAH) to Outperform
-
USA Matrix Rating Changes 10/23
-
Merrill Lynch upgrades Cardinal Health (CAH) to Buy
-
Matrix USA Research Ratings Changes 10/01
-
Credit Suisse Downgrades Cardinal Health (CAH) to Neutral
-
Raymond James upgrades Cardinal Health Inc. (CAH) to Outperform
-
CIBC Starts Cardinal Health (CAH) at Sector Outperformer
-
Cramer Discusses Possible Anti-Competitive Mergers That Could Pass Now, But Not in the Future
-
Goldman Sachs adds Medco Health (MHS) to its Conviction Buy list; Removes CAH
-
JMP Securities Upgrades Cardinal Health (CAH) to Outperform
-
Morgan Stanley upgrades Cardinal Health (CAH) to Overweight
-
UBS upgrades Cardinal Health (CAH) to Buy
-
Jim Cramer Makes Comments on WLP, CAH, AMGN, CELG, ZUMZ, NKE, MHGC & HLT
-
Citigroup Assumes Coverage on Cardinal Health (CAH) with a Hold
-
Goldman Sachs Adds Cardinal Health (CAH) to Conviction Buy List; Removes SYMC and OCR
-
S&P Equity Research Downgrades Cardinal Health (CAH) to Hold
-
JP Morgan removes Cardinal Health (CAH) from their Focus List
-
JMP Securities Initiates CAH
-
Goldman Sachs Upgrades CAH
-
Deutsche Bank Started CAH at Hold
-
Lehman Brothers upgrades CAH to Overweight
-
CSFB Started CAH at Outperform
-
Raymond James Upgrades CAH
-
Bear Stearns Upgrades Cardinal Health
Back to CAH Stock Lookup
